6 12 月, 2022

Domineum and Expert Vision Consulting (EVC) partner to drive Digital Transformation Globally

MECCA, Saudi Arabia, Dec 6, 2022 - (ACN Newswire via SEAPRWire.com) - The International Strategic Collaboration between UK-based Domineum (www.domineum.io) and Saudi-based Expert Vision Consulting (www.evc.sa) outlines the long-term goals between the two companies in line with Saudi Arabia's Vision 2030. Small and Medium Enterprises (SMEs) are among the most significant drivers of economic growth and an important area of focus of the Saudi Vision 2030: creating jobs, encouraging innovation, and strengthening economies. The aim of this partnership is to combine the strengths of each to drive digital transformation by creating access to new markets, new digital products, training, and investment tools.Domineum Blockchain Solutions, which helps governments and businesses digitize their processes to increase efficiency offers a full suite of Blockchain applications including Identity verification solutions, Credential verification, Land and real estate solution, Cargo Tracking Note solutions, and other software for more efficient work, will provide digital transformation services and support small and large companies' growth across the world.Expert Vision Consulting Company (EVC) is a Saudi-based company providing consulting services for decision-makers, enabling them to achieve their innovative business visions for the future. EVC has the capability to translate ideas into reality, serving both the Public Sector & Private Sector in three Areas: Consultation, Solutions, and Innovations.EVC provides consultancy services related to major national projects by supporting many government agencies to achieve the Saudi Arabia Vision 2030 and has earned their clients' trust due to being keen as the first company clients look to as a partner trusted to provide a complete Digital Transformation journey for its clients. With a ranking reputation of being among the fastest-growing tech companies in Saudi Arabia.The MoU was signed on the 25th of November 2022 at EVC headquarters in Mecca Saudi Arabia by DR Basim Zafar, Founder/CEO of Experts Vision Consulting (EVC), and Mohammed Ibrahim Jega, Co-Founder of Domineum Blockchain Solutions. We believe this partnership will accelerate and propel digital transformation in Governments and various industries such as health care, agriculture, fin-tech, education, commerce, energy, supply chains, etc. Dr. Basim Zafar, the Founder/CEO, of Experts Vision Consulting (EVC), said, "As a company that continuously strives to empower the technology sector, we are delighted to collaborate with Domineum to offer multi-tier support to the public and private sector, companies as well as startups. We at EVC consider this partnership as part of the company's responsibility towards societal development."Mohammed Ibrahim Jega, the Co-Founder of Domineum Blockchain Solutions, said "We are delighted to start our fruitful collaboration with EVC Saudi where we will leverage our mutual strength and further accelerate the digital transformation of Government and businesses. Digital transformation is more important than ever and Domineum with its fully integrated and intuitive solutions is a perfect choice for the effortless benefits possible for both governments and individual businesses."For more information:Ejeh JanetE: business@domineum.ioDomineum Blockchain Solutions Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

21 10 月, 2022

Hitachi Astemo Develops Prototype 360-Degree Stereo Vision with Multi-Camera 3D Sensing

TOKYO, Oct 21, 2022 - (JCN Newswire via SEAPRWire.com) - Hitachi Astemo, Ltd. has developed a prototype 360-degree stereo vision system for automated vehicles traveling on regular streets. Based on multi-camera 3D sensing, the all-surrounding sensing system is both high-resolution and highly accurate.Most of the current automated driving systems are limited to highway driving. To enable automated driving systems to be used on general roads, they need to accurately recognize the entire road environment around the vehicle, including a complex mix of objects such as pedestrians and bicycles. Radar and LiDAR systems with high-ranging accuracy, however, still face cost issues before they can see widespread adoption, and all-surrounding-area camera systems, which although are superior in terms of cost, are mainly based on a monocular camera that is still continually evolving to improve accuracy and other issues.Hitachi Astemo, together with the Research and Development Division of Hitachi, Ltd., leveraged their strengths in stereo camera technology to develop a prototype of the 360-degree stereo vision system, using multi-camera 3D sensing that enables distance measurement with the stereo camera technology. Instead of the conventional module consisting of two cameras with the same view angle and being nearly parallel to each other, the camera layout has been made more flexible to use a combination of approximately 10 cameras with different angles of view, including non-parallel cameras to provide stereoscopic 3D vision. By integrating multi-camera 3D sensing into a single in-vehicle camera system, the system realizes 360-degree stereo vision, with a cost advantage, high accuracy and resolution.By generating highly accurate distance information in stereo and all around the vehicle, the system can detect such elements as the distance of a vehicle traveling in the adjacent lane, or a two-wheeled vehicle slipping through a line of cars from behind in a traffic jam. It can estimate the relative speed and direction of movement, and apply this information for vehicle control to avoid collisions and entanglement at intersections. In addition to basic object recognition of objects such as cars, motorcycles, pedestrians, and traffic lanes, the recognition function also includes turn signals, red lights, and brake lights to predict the behavior of other vehicles; as well as traffic signals, road signs, road edges, and free space areas available for driving--all of which are necessary to identify for while driving on ordinary roads.Furthermore, Hitachi Astemo has improved reliability and environmental resistance in camera sensing such as features to resist water droplets and dirt adhering to the lens surface, or shielding the entire lens in the snow. The AI has learned malfunction patterns caused by these factors and can identify malfunction factors that occur in each camera, thereby preventing malfunctions.Going forward, Hitachi Astemo will continue to strengthen its 360-degree stereo vision systems that combine cost advantages with high accuracy and resolution, as well as improved reliability and environmental resistance, with the aim to expand the scope of automated driving systems for use on general roads.Hitachi Astemo is committed to strengthening its business and delivering technological innovation through a strategic business portfolio, which consists of the Powertrain & Safety Systems business, Chassis business, Motorcycle business, Software business and Aftermarket business. Aiming for a better environment globally and growth around the pillars of "green," "digital," and "innovation," we will deliver highly efficient internal combustion engine systems; electric systems that reduce emissions; autonomous driving for improved safety and comfort; advanced driver assistance systems; and advanced chassis systems. Through such advanced mobility solutions, we will contribute to realizing a sustainable society and provide enhanced corporate value for our customers.For more information, please visit the Hitachi Astemo website: www.hitachiastemo.com/en/. Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)

17 10 月, 2022

The Next Vision Capital Announces an Investment from IDG Capital Blockchain

Hanoi, Vietnam, October 17, 2022 – (SEAPRWire) – Recently, the Next Vision Capital, a digital financial platform offering packages to SMEs, is proud to announce an Investment from IDG Capital Blockchain (IDGCB). IDG Capital Blockchain currently manages 40 million dollars and has been investing in over 30 companies under various sectors. Having found the potential of Next Vision Capital (NVC) in the blooming age of Blockchain related technology, IDGCB has made the decision to invest in NVC. Applying blockchain and AI technology to build a financial platform, NVC built a vision to drive the global fund flows to the developing economies, where businesses are thirsty. NVC offers flexible packages to help businesses overcome financial struggles and develop sustainably. Moreover, the team is researching and developing the NFT platform, which applies blockchain technology for SEA SMEs to call for global investment. NVC partners with local banks, using their process of lending out and debt return to check borrower credit before offering the loans. Furthermore, the company cooperates with local insurance firms to secure the bad debts. NVC is gaining trust on the stable business model and attracting investors from over the world. On 6th October 2022, NVC held the Next Vision Capital Investment Show at Suntec Convention & Exhibition Center, to connect with investors in Singapore. More than 100 SEA investors are excited to join and follow up with NVC’s vision. This event marked the first milestone of NVC in the global roadmap. The company has received a committed budget of 30 million USD from Investors to provide loan packages for regional SMEs through NVC lending platform in the next 18 months. NVC constantly endeavors to look for potential funds from global investors with the tempting interest rate. Social Links Facebook: https://www.facebook.com/profile.php?id=100086478185794 Media Contact Brand: The Next Vision Capital Contact: Media team Email: contact@thenvcgroup.com Website: http://thenvcgroup.com/ SOURCE: The Next Vision Capital The article is provided by a third-party content provider. SEAPRWire ( https://www.seaprwire.com/ ) makes no warranties or representations in connection therewith. Any questions, please contact cs/at/SEAPRWire.com Sectors: Top Story, Daily News SEA PRWire: PR distribution in Southeast Asia (Hong Kong: AsiaExcite, EastMud; AsiaEase; Singapore: SEAChronicle, VOASG; NetDace; Thailand: SEAsiabiz, AccessTH; Indonesia: SEATribune, DailyBerita; Philippines: SEATickers, PHNotes; Malaysia: SEANewswire, KULPR; Vietnam: SEANewsDesk, PostVN)

27 9 月, 2022

DENSO Expands Vision Sensor Detection Angle for Subaru Legacy Outback, Crosstrek Models

KARIYA, JAPAN, Sep 27, 2022 - (JCN Newswire via SEAPRWire.com) - DENSO Corporation today announced it has expanded the detection angle of its vision sensor, increasing the sensor's ability to recognize pedestrians and bicycles around a vehicle to improve road safety. The vision sensor is used on some grades of the SUBARU Legacy Outback, announced on April 13, 2022, for the North American market, and the all-new SUBARU Crosstrek(1), unveiled on September 15, 2022, for Japanese market.Vision sensorMany traffic accidents occur when bicyclists and pedestrians suddenly enter roadways from the side. In Japan, such accidents account for about 30% of all traffic accidents involving pedestrians and about 70% of traffic accidents involving children under the age of 12.(2) Drivers are likely to overlook small children and fast bicycles entering the road suddenly from the side, and even if they notice them, struggle to react in time and accidents may occur. Recognizing the importance of the issue, the new car assessment program in Europe (Euro-NCAP) has made it necessary for new vehicles to be able to detect pedestrians and bicyclists from the side of roadways.DENSO decided to tackle this issue and succeeded in expanding the detection angle of its vision sensor to 128 degrees(3). This has made it possible to detect bicycles crossing the road when driving at low speed and meets the assessment conditions(4) stipulated by Euro-NCAP. Thus, the sensor will help to prevent accidents at intersections and other areas where vehicles, motorcycles, bicyclists and pedestrians come and go at various speeds.A wider detection angle can detect many more objects, which means non-hazardous objects are also detected. This makes it critical for the sensor to decipher which is a threat and which is not. For example, when the sensor detects a bicyclist about to cross the road, if the cyclist brakes and stops, the vehicle can keep driving without a collision. However, if the autonomous emergency braking is activated, the vehicle behavior is unpleasant for the driver and is likely to cause other hazards due to its unexpected behavior. The advantages of a wider angle and practical usage have been achieved by detecting objects well in advance with AI technology, determining whether such objects actually pose a risk based on time-series estimation, and minimizing unnecessary vehicle behavior.DENSO remains committed to developing safety products that are satisfactory to users with the aim of spreading safety features to all vehicles.Below is the image comparing this product with a typical product (detection angle of 100 degrees). By expanding the detection angle to 128 degrees, it is possible to detect crossing bicycles more quickly.(1) The all-new Subaru Crosstrek will be officially announced in autumn, 2022(2) Source: Number of traffic accidents by violation/age bracket of pedestrians (whose negligence is serious compared other parties involved in accidents) in "2019 Traffic Statistics" published by the Institute for Traffic Accident Research and Data Analysis(3) The detection angle of vision sensor is based on DENSO's measurement.(4) Assessment conditions for hazard detection in a situation where a bicycle crosses a road at 20 km/h when one's own vehicle is cruising at 10 km/h. The conditions are considered to be difficult to meet in terms of the angle of view; they have been met by expanding the detection angle.References:SUBURU 2023 Outback for North Americawww.subaru.co.jp/news-en/2022_04_13_163459/All-New Subaru Crosstrek for Japanwww.subaru.co.jp/news-en/2022_09_15_174049/ Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)

16 5 月, 2022

Fujitsu Charts Path to Purpose-driven Leadership with “Technology and Service Vision 2022”

TOKYO, May 16, 2022 - (JCN Newswire via SEAPRWire.com) - Fujitsu today revealed its outlook for the future of business and society with the publication of the "Fujitsu Technology and Service Vision 2022." This year's launch marks the tenth anniversary of the Fujitsu Technology and Service Vision, which was first published in 2013 and contains proposals and strategies for achieving a sustainable future through digital innovation.The Fujitsu Technology and Service Vision 2022 offers readers a vision of the future that technology will open up. It sets out how under purpose-driven leadership Fujitsu can deliver change that matters, as well as calling out specific themes that impact change, and how they vary from business to business.Leveraging expertise in digital transformation to realize sustainabilityOver the past 10 years, digital technologies have revolutionized people's daily lives across both businesses and society, and dramatic innovations have transformed the way we do business and interact with the world around us. Leaders in organizations at all levels of the global economy face increasing pressure to prioritize environmental, social, and economic sustainability in their decision-making. They have to deal with the emergence of global threats like climate change, the COVID-19 pandemic, and soaring resource prices. Predicting and preparing for the future has never been more difficult.Since its initial publication in 2013, Fujitsu's Technology and Service Vision has helped readers address the challenges facing business and society with forward thinking. Ideas like 'Human Centric' and 'Trust' that it has promoted have become important transformation themes for management today. In the 2022 edition of Fujitsu's Technology and Service Vision, readers can understand the management and technological priorities that will define the next 10 years.Overview of the Fujitsu Technology and Service Vision 20221. Sustainability TransformationThe mindset of business and social leaders around the world is changing rapidly. Achieving sustainability for the economy, society, and the environment now represents a key management priority, and leaders increasingly have to consider the impact of their business decisions and activities on the global environment. The headline theme for the next 10 years is to drive sustainability transformation through digital innovation, meaning to use technology to shape business to achieve a better impact on the environment, society and economy.2. Technology VisionThe "Fujitsu Technology and Service Vision 2022" proposes four visions for the future that will be realized through the continued evolution of technology.(1) Borderless World: Physical and digital experiences will converge to deliver a human-centric experience that maximizes each person's potential. (2) Dynamic Resilience: Uncertain future scenarios will be digitally rehearsed to build resilience across business and society. (3) Discovery Revolution: Innovation will be accelerated through computing power and next-generation AI to combine the creativity of people and technology. (4) Trust in Everything: Distributed trust will connect people, data and systems safely and securely, supporting a regenerative society.3. Transformation of Business and SocietyFujitsu launched the new global business brand Fujitsu Uvance to realize its future vision and its purpose - "to make the world more sustainable by building trust in society through innovation."Uvance will play a central role in Fujitsu's efforts to resolve social issues including climate change, energy issues, human rights, and food safety beyond the framework of companies and industries. As customers' partner for sustainability transformation, Fujitsu will address important issues in seven key focus areas, including the four vertical areas of cross-industry solutions and the three horizontal areas that support these areas.The Sustainable Development Goals (SDGs) adopted by the United Nations in 2015 represent a set of common goals to be achieved worldwide by 2030. Fujitsu's purpose -- "to make the world more sustainable by building trust in society through innovation" --is a promise to contribute to the vision of a better future empowered by the SDGs.About FujitsuFujitsu's purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$32 billion) for the fiscal year ended March 31, 2022 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com. Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)

28 1 月, 2022

德视佳收购London Vision Clinic Partners Limited 100%已发行股本

HONG KONG, Jan 28, 2022 - (亚太商讯 via SEAPRWire.com) - 领先的全球视力矫正服务提供商─德视佳国际眼科有限公司(「德视佳」或「公司」，连同其附属公司为「集团」，股份代号：1846)欣然宣布，德视佳全资附属公司EuroEyes UK与 London Vision Clinic Partners Limited(「LoVC」)的法定及实益拥有人(「卖方」)订立购股协议，收购LoVC的全部已发行股本。根据购股协议，此次收购的完成现金代价及代价股份合计1,313万英镑；或有代价及盈利支付代价最高1,775万英镑，并可能进行代价调整。最高代价不超过3,087.5万英镑。或有现金代价及盈利支付方面，在第一种盈利目标下，目标公司如能连续四年保持12.5%的利润增长，德视佳将授予价值300万英镑的股份；而在第二种更高速的盈利增长目标下，目标公司如能连续三年实现35%的利润增速，并在第四年实现25%的盈利增速，德视佳将支付975万英镑的现金奖励。于完成后，卖方（或根据购股协议的条款及条件获提名的合伙人）将持有经配发及发行完成代价股份扩大后德视佳已发行股本约1.20%。完成代价股份将按每股完成代价股份8.323港元的发行价发行，发行价较于截至紧接2022年1月20日前交易日止的五个连续交易日于联交所所报的平均收市价每股8.72港元折让约4.6%。该持股将作为股权激励，激励及留存London Vision Clinic的合伙人及核心医生。London Vision Clinic Partners Limited 为视力矫正行业的领先品牌之一，主要提供优质的视力矫正服务，包括PRK、LASIK、SMILE、后房型人工晶体(ICL)植入术以及屈旋光性白内障手术。凭借其细致全面的测试及诊断能力、其在向专家外科医生提供培训及处理复杂病例方面的专业知识，及其享誉全球的声誉，LoVC一直为英国市场的领导者及价格领先者。此外，LoVC是向眼睛老化导致的老花眼患者提供激光视力矫正方案的全球领先者之一，以改善他们的阅读视力。其创办人Dan Zoltan Reinstein教授因在屈光手术领域的发明及重大贡献而在全球享有盛誉，包括发明治疗眼睛老化导致的老花眼患者阅读视力的PRESBYOND®激光融合视觉疗法（PRESBYOND® Laser Blended Vision，已由卡尔蔡司医疗科技商业化），其旨在治疗40岁左右近距离阅读视力下降的老花眼患者。PRESBYOND®提供了一种通过LASIK手术治疗年轻老花眼患者的新方法，无需对眼睛内部进行手术以更换自然晶状体。这与德视佳现有的三焦点人工晶体置换术互为补充，使德视佳在使用现有准分子激光仪器的基础上，拓展40岁左右的老花眼患者群体。此外，London Vision Clinic拥有丰富的人才储备，合并后，德视佳将继续聘用这些业内的资深专家，增强自身的专业实力。其中，Reinstein教授将担任集团国际医疗顾问委员会的医疗总监，使集团能够接触到更多早期可能患有老花眼的患者，为德视佳的专家团队增添巨大价值。Reinstein教授是分层角膜测绘和成像及生物测定领域的生物工程先驱、发明者和开创者。其开发了超高频数字超声扫描技术，发明了Arcscan Insight 100 机器人超声成像以及光学相干层析(OCT)设备，使诊断更为精准，从而提高了激光角膜与ICL植入术的安全性及准确性。其专利生物测定技术的应用为LASIK及SMILE的的临床和科学发展做出了重大贡献。此外，LoVC全资附属公司London Vision Clinic Training将展开收购后业务，主要从事提供屈光手术相关的在线及线下培训。Reinstein教授将为London Vision Clinic Training的主讲人和培训师之一。此外，在目标公司财务状况方面，London Vision Clinic Partners Limited展现出较强的增长潜力，由2020年全年息税前利润9万4千英镑大幅增至2021年的219万英镑，这一增长主要是由于目标公司于2021年初开始，在经营方式及运营管理方面做出了积极优化及改进。德视佳的创始人，董事长兼首席执行官约根森博士表示：「集团一直积极扩大现有的欧洲版图，收购LoVC绝对符合我们的增长战略。我们相信是次收购有助集团迅速进军伦敦高端市场，并提供屈光及老花眼手术，从而产生协同效应，支持集团的长期增长，以及巩固市场领先地位。随着LoVC 及其 PRESBYOND®激光融合视觉疗法并入德视佳，集团能够接触更多早期可能患有老花眼的患者。在完全LoVC 收购后，我们计划于未来一至两年于伦敦开设一家新诊所，以进一步扩大我们的服务网络，为更多患者提供优质的眼科护理服务。」关于德视佳国际眼科有限公司德视佳成立于1993年，是视力矫正行业的领先品牌之一，该产品结合了德国眼科学的卓越经验和超过25年的经验以及个性化的客户服务。德视佳是为数不多，具有广泛地理覆盖范围的眼科诊所之一，业务遍及德国、丹麦和中国。该集团的视力矫正服务包括：(i)屈光激光手术(包括ReLEx Smile和Femto LASIK)；(ii)晶体植入手术(ICL)；(iii)晶体置换手术(包括单焦点和三焦点晶体置换手术)和(iv)其他(包括PRK / LASEK和ICRS植入术)。此新闻稿由博达浩华国际财经传讯公司代表德视佳国际眼科有限公司发布。如有垂询，请联络：博达浩华国际财经传讯公司电邮：euroeyes.hk@pordahavas.com Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)

28 1 月, 2022

EuroEyes Acquires 100% Issued Shares in London Vision Clinic Partners Limited

HONG KONG, Jan 28, 2022 - (ACN Newswire via SEAPRWire.com) - EuroEyes International Eye Clinic Limited ("EuroEyes" or the "Company", together with its subsidiaries, the "Group", stock code: 1846), a leading global vision correction service provider, is pleased to announce that EuroEyes UK, a wholly-owned subsidiary of the Company, has entered into a Share Purchase Agreement ("Share Purchase Agreement") to acquire the entire issued shares in London Vision Clinic Partners Limited ("LoVC") with the legal and beneficial owners of LoVC ("Sellers").According to the share purchase agreement, the total cash consideration and consideration shares for the acquisition shall be GBP13,130,000; the maximum amount of earn out payment shall be GBP17,745,000, and subject to the Consideration Adjustment. The maximum consideration for the Acquisition shall be GBP 30,875,000. In terms of earn out payment, under the first profit target, if the Seller maintains an EBIT growth of 12.5% for four consecutive years, EuroEyes shall procure the allotment and issue to the Seller such number of shares having an aggregate value of up to GBP3,120,000; Under the second profit target, if the Seller achieves an EBIT growth rate of 35% for three consecutive years, and 25% in the fourth year, Euroeyes shall pay GBP 9,750,000 to the Seller.Upon Completion, the Seller (or the Partners as nominated in accordance with the terms and conditions of the Share Purchase Agreement) will hold approximately 1.20% of the issued share capital of EuroEyes as enlarged by the allotment and issue of the Completion Consideration Shares. The Completion Consideration Shares will be issued at the issue price of HK$8.323 per Completion Consideration Share which represents a discount of approximately 6.9% to the average closing price of HK$8.94 per Share as quoted on the Stock Exchange on the five consecutive trading days ended on the trading day immediately preceding 20 January 2022. The shareholding will serve as an share incentive to motivate and retain London Vision Clinic's partners and key surgeons. London Vision Clinic Partners Limited is one of the leading brands in the vision correction industry and principally engaged in the provision of premium vision correction services, including PRK, LASIK, SMILE, phakic lens (ICL) surgery and refractive cataract surgery. It has been the market segment and price leader in the UK with its capabilities in conducting detailed and comprehensive testing and diagnosis and has a world reputation for expertise in providing training to specialist surgeons and managing complicated cases.Moreover, LoVC is a world leader in offering laser vision correction option for reading vision in ageing eyes (presbyopia). Its founder, Professor Dan Zoltan Reinstein, has garnered worldwide reputation for his inventions and major contributions to the refractive surgery field, including the invention of the PRESBYOND Laser Blended Vision treatment as commercialised by Carl Zeiss Meditec for presbyopia which is designed to treat patients from the age of 40 years old, who have developed presbyopia (decreased ability to read up close). PRESBYOND provides an additional method of treating younger patients with presbyopia by a LASIK procedure, which avoids the need to perform surgery inside the eye to replace the natural lens. Presbonyd will a perfect addition to EuroEyes' trifocal lens exchange surgery, which enables EuroEyes to treat a larger group of presbyopia patients over 40 years old without buying new equitments.In addition, London Vision Clinic has a talent pool of high-quality surgeons and doctors. Upon completion of the Acquisition, EuroEyes will continue to hire the expert group to further strengthen its medical expertise. What's more, Professor Reinstein will serve as a medical director of the international medical advisory board of the Group, which will add tremendous value to EuroEye's expert team. Professor Reinstein is also a bioengineering pioneer, inventor and developer in the field of layered corneal mapping and imaging and biometry. He had pioneered corneal imaging and biometry with very high-frequency digital ultrasound scanning, invented the Arcscan Insight 100 robotic scanner as well as optical coherence tomography (OCT) devices, enabling superior diagnostic capabilities to improve the safety and accuracy of both laser corneal and ICL surgery. Application of his patented biometric technologies has resulted in major contributions to the clinical and scientific development of both LASIK and SMILE.Moreover, London Vision Clinic Training, a wholly-owned subsidiary of LoVC, will start business afer acquisition, and will be principally engaged in the provision of online and offline training relating to refractive surgery. Professor Reinstein will be one of the key speakers and trainers at London Vision Clinic Training.In addition, in terms of the financial position of the target company, London Vision Clinic Partners Limited has shown strong growth potential, with a substantial increase in EBIT from GBP 94,000 in 2020 to GBP 2.19 million in 2021. This growth is mainly due to the proactive optimizations and improvements in its business model and operation management made by LoVC started in early 2021.Dr. Jorn Slot Jorgensen, Founder, Chairman and CEO of EuroEyes said, "The Group has been actively expanding its current footprint in Europe and the acquisition of LoVC is definitely in line with our growth strategy. We believe that the acquisition will enable the Group to quickly tap into the high-end London market for refractive and presbyopic surgeries, create synergy and support the long-term growth of the Group, thereby enhancing its market leader status. With the additions of LoVC and its PRESBYOND Laser Blended Vision treatment, the Group will be able to reach out to more potential patients who are suffering from presbyopia at an early stage. Following the acquisition of LoVC, we plan to open a new clinic in London within 1-2 year, to further expand our service network and provide more patients with high-quality eye care services."About EuroEyes International Eye Clinic LimitedEuroEyes was established in 1993 and is one of the leading brands in the vision correction industry that combines German ophthalmology excellence and over 25 years of experience with individualised customer care. EuroEyes is one of the few eye clinic groups with a far-reaching geographical coverage, with operations in Germany, Denmark and the PRC. The Group's vision correction services include (i) refractive laser surgery (which includes ReLEx smile and Femto LASIK); (ii) phakic lens (ICL) surgery; (iii) lens exchange surgery (which includes the monofocal and trifocal lens exchange surgery) and (iv) others (which include PRK/LASEK and ICRS implantation). Issued by Porda Havas International Finance Communications Group for and on behalf of EuroEyes International Eye Clinic Limited. For further information, please contact: Porda Havas International Finance Communications Group Email: euroeyes.hk@pordahavas.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

20 10 月, 2021

AAC Technologies’ Investment in SWIR Vision Systems Inc.

HONG KONG, Oct 20, 2021 - (ACN Newswire via SEAPRWire.com) - AAC Technologies Holdings Inc. ("AAC", HKEx: 2018), announced investment in the Series A financing round for SWIR Vision Systems Inc. ("SWIR Vision Systems"). SWIR Vision Systems is a company pioneering the next generation of image sensor solutions for industrial automation, consumer electronics, AR/VR system, autonomous vehicles and other applications. This investment is in line with AAC's long-term strategic to further expand in the optics industry on the back of the company's unique Wafer-level Glass ("WLG") technology and high-end precision manufacturing capabilities. "We are appreciative of this strong vote of investor confidence in our team and our technology," said George Wildeman CEO, SWIR Vision Systems. "The reception we've encountered in the industry has been extraordinary. We look forward to expanding our business in the industrial imaging market, while working with the world's top automotive and consumer electronics companies to explore applications of our fully scalable CMOS-based SWIR sensor solutions".Antonino Parrinello, Head of Corporate Development at AAC Technologies said, "We are also pleased to participate in the Series A financing round for SWIR Vision Systems. SWIR Vision's has the cutting-edge sensor technology, CMOS-based Acuros CQD image sensors which promise to usher in a new era of advanced 2D and 3D imaging sensors that meet the challenging cost and performance requirements in key strategic markets such as automotive, consumer electronics, and industrial imaging."It is reported that, based on a unique quantum-dot photodiode sensor design, SWIR Vision's patented sensor solutions have delivered the highest resolution, commercially available short-wavelength infrared ("SWIR") cameras in the world. The cameras are already in use inspecting high volume production semiconductor chips in the world's largest semiconductor chip fab. SWIR Vision plans to use its Series A funding to advance the company's CQD sensor solutions, to grow the company's SWIR camera business in the global industrial and defense markets, and to engage strategic customers in the consumer electronics, automotive and advanced sensor markets. Copyright 2021 ACN Newswire. All rights reserved. (via SEAPRWire)

14 7 月, 2021

NEC’s artificial intelligence (AI) supports doctors to determine if colorectal lesions are potentially neoplastic

TOKYO, Jul 14, 2021 - (JCN Newswire via SEAPRWire.com) - NEC Corporation (NEC; TSE: 6701) announced today the development of an AI technology for supporting doctors in determining if colorectal lesions are neoplastic or non-neoplastic. NEC developed a new technology, called "Cx20," while seeking to assist in the early detection of colorectal lesions. Cx20 has already met the requirements for CE marking, a European safety, health and environmental protection standard, and will be integrated in the medical device AI diagnostic support software "WISE VISION Endoscopy" (1), with sales expected to start in Europe later this year.The Cx20 function supports the identification of disease. During examinations, suspected lesions are automatically detected through video taken by endoscope devices. Doctors then extract still images (left) and analysis results are soon displayed (right)This software connects and interacts with existing endoscopic equipment and automatically notifies users if a lesion is possibly neoplastic based on images captured during endoscopy procedures. The software then becomes an extra tool immediately available to assist endoscopists in the differentiation of lesions and reduces the burden on patients.Colorectal cancer originates from precancerous lesions (colorectal neoplastic polyps) and it is possible to suppress its progression by detecting and removing lesions at an early stage during endoscopy procedures. It is, however, sometimes difficult for endoscopists to visually distinguish between neoplastic and non-neoplastic lesions during endoscopy examinations, resulting in unnecessary biopsies and removal of non-neoplastic lesions, thereby causing additional stress and discomfort to patients. Colorectal cancer is said to be the second-largest cancer (2) in the European region, and the latest version of WISE VISION Endoscopy, which launches first in Europe, promises to help doctors address this challenging issue.To improve the chances of identifying if colorectal lesions are possibly neoplastic, and so to help endoscopists in their decision process, NEC developed a new technology where the learning power of AI is used to combine information of endoscopy images and data from the findings of expert physicians. Specifically, the technology analyzes still images of lesions taken with endoscopy devices, and if the AI determines that a colorectal lesion is likely to be neoplastic a "High possibility" notification message is displayed.NEC and the National Cancer Center Japan have been collaborating since 2016 to develop a technology that automatically detects suspected colorectal lesions during endoscopy examinations. NEC began sales of software incorporating this technology in January of this year (3). With the addition of this function in Europe, WISE VISION Endoscopy aims to help reduce the burden on doctors and patients by providing additional and immediately beneficial support during the examination process. In developing this solution NEC applied its face recognition technology, belonging to its portfolio of cutting edge AI based technologies (labelled "NEC the WISE"), which has been highly evaluated by the National Institute of Standards and Technology (NIST) in the United States (4).In the future, NEC will further promote joint research with the National Cancer Center Japan to further enhance the performance of its AI technology and to assist endoscopists with its usage.About WISE VISION EndoscopyThis software can be connected to endoscopes from leading endoscope manufacturers (5). By simply connecting an existing endoscope to a monitor and terminal equipped with the software, users can start using it immediately. The system issues sound notifications when a candidate lesion has been located, and the type and volume of the notification can be customized at any time according to user preferences. Moreover, a highly visible user interface allows intuitive operation, enabling endoscopists to smoothly proceed with examinations.Going forward, NEC aims to accelerate digital transformation in the medical field by providing safe and secure products and services, including AI, to promote a healthy, and sustainable society, where individuals can thrive from the utilization of advanced IT technologies.(1) "WISE VISION" is a registered trademark of NEC Corporation in the United States of America, the European Union and the United Kingdom.(2) According to United European Gastroenterologynew windowhttps://ueg.eu/p/78#(3) NEC releases "WISE VISION Endoscopy" in Europe and Japanhttps://www.nec.com/en/press/202101/global_20210112_01.htmlYamada M, Saito Y, Imaoka H, et al. Development of a real-time endoscopic image diagnosis support system using deep learning technology in colonoscopy. Sci Rep. 2019;9:14465. doi: 10.1038/s41598-019-50567-5. PMID: 31594962(4) NEC Face Recognition Technology Ranks First in NIST Accuracy Testinghttps://www.nec.com/en/press/201910/global_20191003_01.html(5) Connectivity and operations have been confirmed with the following endoscopes.Olympus EVIS LUCERA ELITE Video System Center CV-290FUJIFILM ELUXEO video processor VP-7000 Copyright 2021 JCN Newswire. All rights reserved. (via SEAPRWire)

11 6 月, 2021

S’pore firm being investigated for illegal mask manufacturing, repackaging

SINGAPORE - A local company is being investigated for manufacturing surgical masks here without a licence, the Health Sciences Authority (HSA) said on Friday (June 11). This is the first time a firm is suspected of that action. The manufacturing was observed taking place in an unhygienic and makeshift environment at Vision Empire International's facility in Ubi Crescent, with the masks placed in carton boxes and left out in the open. A total of 33 cartons, each containing about 2,500 masks, were seized. Under the Health Products Act, firms are required to have a licence from HSA to manufacture surgical masks. Vision Empire International was also suspected to have imported surgical masks from overseas before repackaging, rebranding and reselling them without having a licence to do so. Both manufactured and repackaged masks were sold under the brand Vision Empire Healthcare. They were sold on local e-commerce platforms for between $10 and $22 per box of 50 masks, according to preliminary investigations. Consumers who have made purchases are advised to stop using them immediately, HSA said. Both manufactured and repackaged masks were sold under the brand Vision Empire Healthcare. PHOTO: HEALTH SCIENCES AUTHORITY It added that these listings have been removed with the assistance of the platform administrators, and Vision Empire International has been directed to recall the products. Investigations are ongoing, the authority said. Manufacturers and repackers of surgical masks are licensed by HSA to ensure good quality and safety for use. The manufacturing was observed taking place in an unhygienic and makeshift environment, with the produced masks placed in carton boxes and left out in the open. PHOTO: HEALTH SCIENCES AUTHORITY The manufacturing was observed taking place in an unhygienic and makeshift environment at Vision Empire International's facility in Ubi Crescent. PHOTO: HEALTH SCIENCES AUTHORITY In its release, the authority said surgical masks from unlicensed facilities have not been verified to meet the standards of quality, filtration capability and breathability. "Sub-standard masks may not provide the desirable level of protection to the wearer," it added, noting that masks made, repackaged and/or stored in unsanitary conditions could be contaminated. "Wearing such masks may increase the users' risk of developing skin irritation, respiratory symptoms or infections," HSA said. It will take strong enforcement action against those who illegally manufacture and/or supply masks. Those who do so could be prosecuted and, if convicted, jailed for up to two years or fined up to $50,000, or both. More on this topic Related Story Wear a mask with high filtration capability, not just any cloth mask Related Story HSA removes more than 3,200 listings of illegal health products from e-commerce sites

29 5 月, 2021

NEC’s AI Supports Doctors to Detect Neoplasia in Barrett’s Esophagus during Endoscopic Procedures

TOKYO, May 28, 2021 - (JCN Newswire via SEAPRWire.com) - NEC Corporation (NEC; TSE: 6701) today announced the development of an AI technology for supporting doctors to detect neoplasia in Barrett's esophagus during endoscopic procedures. This is the world's first technology of its kind to comply with the requirements for CE mark labeling, a European safety, health and environmental protection standard (1), and is being released as WISE VISION Endoscopy, where it will soon be available in Europe to help doctors in the detection of Barrett's neoplasia (2). Provided by Professor Pradeep Bhandari: "Once the neoplasia is found, the system takes a still image and transfers it to the top right corner of a screen as a reference image for endoscopists. It also has a heat map which shows the area of the AI-predicted neoplasia."This software is connected to endoscopy processors and automatically notifies users of potential Barrett's neoplasia from images captured during endoscopic procedures.Barrett's esophagus is a pre-cancerous condition in which the inner lining of the esophagus is replaced by a lining that resembles that of the stomach. Worldwide prevalence of Barrett's esophagus is 1% of the entire population but much higher (7%) in patients with acid-reflux symptoms (3). Patients with Barrett's esophagus have 30-40 fold higher risk of developing cancer of the esophagus as compared to the normal population (4). However, if this cancer can be detected at an early stage, then it can be removed through the endoscope and a patient can be cured. Patients with Barrett's esophagus have to undergo regular endoscopy (every 2-3 years) to detect early cancer, but this is still challenging as the early changes of cancer are very subtle and difficult to identify. As a result, current recommendations are to take multiple random biopsies throughout the length of Barrett's esophagus to identify any focus of early cancer (5, 6). However, random biopsies are expensive and time consuming and are only performed in accordance with official clinical guidelines by an estimated 30-51% of endoscopists (7, 8, 9, 10). Consequently, it has been pointed out that up to 40% of neoplasia may be missed (7) resulting in delayed cancer diagnosis and poor outcomes for the patients. To help resolve this issue, NEC collaborated with Professor Pradeep Bhandari (Portsmouth, UK), Chair of the European Society of Gastrointestinal Endoscopy (ESGE) Research Committee, in development of this new technology to support doctors to detect Barrett's neoplasia during examination. WISE VISION Endoscopy has been trained with more than 1 million Barrett's esophagus endoscopy images, together with the knowledge of expert endoscopists, enabling it to meet the requirements for CE mark labeling. In developing this solution, NEC applied its face recognition technology that has been highly evaluated (11) by the National Institute of Standards and Technology (NIST) in the United States, and belongs to NEC's portfolio of cutting-edge AI technologies, "NEC the WISE."On clinical evaluation, WISE VISION Endoscopy could find more than 90% of Barrett's neoplasia (12). WISE VISION Endoscopy is expected to significantly reduce the neoplasia miss rate during endoscopy and improve the outcome for patients with Barrett's esophagus all around the world. The abstract applying this technology has received the Gut Award from the British Society of Gastroenterology (BSG), which was presented in the plenary session of the BSG Campus. It was also selected one of the best endoscopy abstracts in UEG Week Virtual 2020 held by United European Gastroenterology. "I am delighted that NEC, as one of the world's leaders in AI technology, has entered the field of endoscopy and developed WISE VISION? Endoscopy to detect and help manage Gastrointestinal neoplasia. Barrett's neoplasia can be very flat and easily missed during endoscopy, despite taking multiple biopsies. I worked with NEC to develop the Barrett's neoplasia detection arm of WISE VISION? Endoscopy and am super impressed by the speed with which NEC has produced this as the World's first AI engine to obtain the CE mark for notifying Barrett's neoplasia. "WISE VISION Endoscopy can notify very flat and subtle lesions and much faster than most endoscopists. Once the neoplasia is found, this system takes a still image and transfers it to the top right corner of a screen as a reference image for endoscopists. It doesn't stop here, as it also has a heat map which shows the area of the AI-predicted neoplasia. WISE VISION? Endoscopy is set to revolutionize the endoscopic detection and management of Barrett's neoplasia in the western world. I'm sure that clinicians involved in the management of Barrett's esophagus are looking forward to the dawn of this new (Wise) era in Endoscopy," said Professor Pradeep Bhandari, Chair of the ESGE Research Committee.About WISE VISION EndoscopyThis software can be connected to endoscopes from three leading endoscope manufacturers (13). By simply connecting an existing endoscope to a monitor and terminal equipped with the software, users can start using it immediately. The system issues sound notifications when a candidate lesion has been located, and the type and volume of the notification can be customized at any time according to user preferences. Moreover, a highly visible user interface allows intuitive operation, enabling specialists to smoothly proceed with examinations. Going forward, NEC aims to accelerate digital transformation in the medical field by providing safe and secure products and services, including AI, to promote a healthy, and sustainable society, where individuals can thrive from the utilization of advanced IT technologies.(1) Source: NEC Corporation(2) "WISE VISION" is a registered trademark of NEC Corporation in the United States of America, the European Union and the United Kingdom.(3) Marques de S? I, Marcos P, Sharma P, Dinis-Ribeiro M. The global prevalence of Barrett's esophagus: A systematic review of the published literature. United European Gastroenterol J. 2020;8(9):1086-1105. doi:10.1177/2050640620939376(4) Sharma P. Clinical practice. Barrett's esophagus. N Engl J Med. 2009 Dec 24;361(26):2548-56. doi: 10.1056/NEJMcp0902173. Erratum in: N Engl J Med. 2010 Apr 15;362(15):1450. PMID: 20032324.(5) Weusten B, Bisschops R, Coron E, Dinis-Ribeiro M, Dumonceau JM, Esteban JM, Hassan C, Pech O, Repici A, Bergman J, di Pietro M. Endoscopic management of Barrett's esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy. 2017 Feb;49(2):191-198. doi: 10.1055/s-0042-122140. Epub 2017 Jan 25. PMID: 28122386.(6) ASGE STANDARDS OF PRACTICE COMMITTEE, Qumseya B, Sultan S, Bain P, Jamil L, Jacobson B, Anandasabapathy S, Agrawal D, Buxbaum JL, Fishman DS, Gurudu SR, Jue TL, Kripalani S, Lee JK, Khashab MA, Naveed M, Thosani NC, Yang J, DeWitt J, Wani S; ASGE Standards of Practice Committee Chair. ASGE guideline on screening and surveillance of Barrett's esophagus. Gastrointest Endosc. 2019 Sep;90(3):335-359.e2. doi: 10.1016/j.gie.2019.05.012. PMID: 31439127.(7) Kariv R, Plesec TP, Goldblum JR, et al. The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2009 Jun;7(6):653-8; quiz 06. PubMed PMID: 19264576. Epub 2009/03/07. eng.(8) Shaheen NJ, Falk GW, Iyer PG, Gerson LB, American College of G. ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus. Am J Gastroenterol. 2016;(9) Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology. 2011 Mar;140(3):e18-52; quiz e13.(10) Abrams JA, Kapel RC, Lindberg GM, Saboorian MH, Genta RM, Neugut AI, et al. Adherence to Biopsy Guidelines for Barrett's Esophagus Surveillance in the Community Setting in the United States. Clin Gastroenterol Hepatol [Internet]. 2009 Jul 1 [cited 2018 Nov 16];7(7):736?42.(11) NEC Face Recognition Technology Ranks First in NIST Accuracy Testinghttps://www.nec.com/en/press/201910/global_20191003_01.html(12) Presented at ESGE Days 2021 held by European Society of Gastrointestinal Endoscopy(13) Connectivity and operations have been confirmed with the following endoscopes.Olympus EVIS LUCERA ELITE Video System Center CV-290Olympus EVIS EXERA III Video System Center CV-190FUJIFILM ELUXEO video processor VP-7000PENTAX Medical OPTIVISTA EPK-i7010 video processorPENTAX Medical OPTIVISTA EPK-i7000 video processorFor More InformationURL: https://www.nec.com/en/global/wisevision/?id=confirmAbout NEC CorporationNEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of ?Orchestrating a brighter world.? NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com. Copyright 2021 JCN Newswire. All rights reserved. (via SEAPRWire)